Gerofit Exercise for Sickle Cell Disease
(SICKLE-FIT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a personalized exercise program can improve physical health and quality of life for adults with sickle cell disease (SCD), a condition affecting red blood cells. Participants will follow an exercise routine adapted from the Gerofit Exercise Program, conducted virtually three times a week for up to 12 weeks. The trial seeks individuals with any type of sickle cell disease who understand and speak English. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance daily living for those with SCD.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the Gerofit Exercise Program is safe for adults with Sickle Cell Disease?
Research has shown that the Gerofit Exercise Program is safe for people with sickle cell disease (SCD). In past studies, participants, especially older adults with SCD, found the program enjoyable and safe. Most reported health issues were unrelated to the exercise program, indicating it is well-tolerated. The program also improves health, mental and physical abilities, and overall well-being. This provides a positive view of its safety for those considering joining the trial.12345
Why are researchers excited about this trial?
The Gerofit Exercise Program is unique because it brings a new approach to managing sickle cell disease by focusing on structured physical activity. Unlike standard treatments like hydroxyurea or blood transfusions, which aim to directly modify blood properties or manage symptoms, this program emphasizes regular exercise to potentially improve overall health and quality of life for patients. Researchers are excited about this trial because it explores the potential benefits of exercise in a virtual setting, offering a non-invasive and accessible way for participants to engage in health-promoting activities from the comfort of their homes.
What evidence suggests that the Gerofit Exercise Program is effective for improving physical health and quality of life in adults with Sickle Cell Disease?
Research has shown that the Gerofit Exercise Program, which participants in this trial will follow, can boost physical health and quality of life. In a study with older adults who had sickle cell disease, 93% of participants rated their exercise results as good or very good, and many expressed satisfaction with the program's effects. The program has also improved health, mental function, and well-being in other groups. This suggests that the Gerofit Exercise Program might effectively manage symptoms of sickle cell disease.15678
Who Is on the Research Team?
Charity I Oyedeji, MD
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for adults with Sickle Cell Disease (SCD) who can speak English fluently. Participants must have a confirmed diagnosis of any genotype of SCD. It's not suitable for those with unstable heart disease, severe cognitive issues, wheelchair users, oxygen-dependent individuals, or those who've had successful stem cell transplants for SCD.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a personalized exercise program adapted from Gerofit, exercising 3 days a week for up to 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, including Sickle Cell Disease Functional Assessment every 3 months
What Are the Treatments Tested in This Trial?
Interventions
- Gerofit Exercise Program
Gerofit Exercise Program is already approved in United States for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator